Clinical trial
Outcome of Patients With Severe Functional Tricuspid Regurgitation
NCT05825898 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Outcome of Patients With Severe Functional Tricuspid Regurgitation
- Lead sponsor
- Ottawa Heart Institute Research Corporation
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- September 1, 2022
- Completion date
- December 31, 2026
- Enrollment
- 3,500 (estimated)
- Sites
- 44
Conditions
As the registry lists them; a condition with its own page is linked.
tricuspid regurgitation